Bipolar Depression

Articles

ORLANDO, Fla.—A friendly debate between 2 thought leaders followed by a vote at Psych Congress 2018 exhibited the divide that persists on a controversial topic in mental health.

ORLANDO, Fla.—Mental health clinicians should avoid antidepressants in patients with depressive symptoms that coexist with symptoms of mania, Joseph F. Goldberg, MD, advised attendees at Psych Congress 2018.

ORLANDO, Fla.—The atypical antipsychotic cariprazine outperformed placebo in reducing depressive symptoms in patients with bipolar I disorder, according to a poster presented at Psych Congress 2018.

Eating a healthy diet, particularly a traditional Mediterranean diet, may help protect against depression, according to a systematic review and meta-analysis.

People with depression or bipolar disorder were found to have a larger hypothalamus, compared with healthy control subjects, in a study published in Acta Psychiatrica Scandinavia.

Pages

Posters

Gordon Loewen, PhD; Rosa Luo, EM; Evan Smith, BS; Grace Liang, PhD; Khodayar Farahmand, PharmD; Haig Bozigian, PhD; Christopher OкBrien, MD
Hubert Fernandez, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Karen Anderson, MD
Melissa DelBello, MD; Robert Goldman, PhD; Debra Phillips, BA; Ling Deng, PhD; Josephine Cucchiaro, PhD; Antony Loebel, MD
Andrei Pikalov, MD, PhD; Joyce Tsai, PhD; Yongcai Mao, PhD; Michael Tocco, PhD; Antony Loebel, MD
Roger McIntyre, MD, FRCPC; Dao Thai-Cuarto, PharmD; Joshua Burke, MS; Scott Siegert, PharmD; Dimitri Grigoriadis, PhD

Pages

Video

Terence Ketter, MD, Professor of Psychiatry at Stanford University in Stanford, California, discusses how clinicians can identify which patients with bipolar disorder will be treatment-resistant.

Terence Ketter, MD, Professor of Psychiatry at Stanford University in Stanford, California, discusses some tools which are underutilized in treatment of patients with treatment-resistant bipolar disorder.

Terence Ketter, MD, Professor of Psychiatry at Stanford University in Stanford, California, discusses how often first-line treatments for bipolar disorder have inadequate outcomes.

Pages